Cellular Dynamics International Announces Agreement With AstraZeneca PLC on Use of iPSC-derived Human Cells in Drug Discovery Research

MADISON, Wis., Jan. 3, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery throu…

---

Isis Pharmaceuticals, Inc. Strikes Cancer Targets Agreement Worth $31 Million With AstraZeneca PLC

CARLSBAD, Calif., Dec. 11, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca announced today a strategic alliance for the discovery and development of novel generation ant…

---

XenoPort, GSK terminate collaboration on Horizant tablets

XenoPort and Glaxo Group (GSK) have agreed to terminate their collaboration agreement concerning Horizant extended-release tablets, for which GSK held commercialization rights and certain development…

---

Augurex Announces Exclusive License Agreement with Quest Diagnostics for the Development of Arthritis Biomarker 14-3-3 eta as a Testing Service in the U.S.

Augurex Life Sciences Corp. recently announced that it has formed an exclusive license agreement with Quest Diagnostics, for the development of a clinical laboratory-developed testing service for the.

---